Verona Pharma, Inc., A Subsidiary Of Merck & Co., Inc. (rahway, New Jersey Usa

This study tested an inhaled medication called glycopyrrolate in 46 people with COPD. Participants received three different doses of the drug and a placebo over separate one-week periods. The goal was to see if the drug improves lung function and is safe. This is an early-stage t…

This study tested a new combination of two inhaled drugs, ensifentrine and glycopyrrolate, in 33 adults with COPD. The goal was to see how the drugs move through the body, how well they open airways, and if they are safe. Each person received single doses of the combination and e…